Reduction of Hepatic Steatosis, Oxidative Stress, Inflammation, Ballooning and Insulin Resistance After Therapy with Safranal in NAFLD Animal Model: A New Approach

References

• Samuel VT, Shulman GI. Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases. Cell Metab. 2018;27(1):22–41. doi:10.1016/j.cmet.2017.08.002
   PubMed Web of Science ®Google Scholar
• Polyzos SA, Kountouras J, Mantzoros CS. Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics. Metabolism. 2019;92:82–97. doi:10.1016/j.metabol.2018.11.014
   PubMed Web of Science ®Google Scholar
• Niederreiter L, Tilg H. Cytokines and fatty liver diseases. Liver Res. 2018;2(1):14–20. doi:10.1016/j.livres.2018.03.003
   Google Scholar
• Velasco JV-R, García-Jiménez E, García-Zermeño K, et al. Extrahepatic complications of non-alcoholic fatty liver disease. Revista de Gastroenterología de México. 2019;84(4):472–481. doi:10.1016/j.rgmxen.2019.05.004
   Web of Science ®Google Scholar
• Lian C-Y, Zhai Z-Z, Li Z-F, Wang L. High fat diet-triggered non-alcoholic fatty liver disease: a review of proposed mechanisms. Chem Biol Interact. 2020;330:109199. doi:10.1016/j.cbi.2020.109199
   PubMed Web of Science ®Google Scholar
• Ore A, Akinloye OA. Oxidative stress and antioxidant biomarkers in clinical and experimental models of non-alcoholic fatty liver disease. Medicina. 2019;55(2):26. doi:10.3390/medicina55020026
   PubMed Web of Science ®Google Scholar
• Spahis S, Delvin E, Borys J-M, Levy E. Oxidative stress as a critical factor in nonalcoholic fatty liver disease pathogenesis. Antioxid Redox Signal. 2017;26(10):519–541. doi:10.1089/ars.2016.6776
   PubMed Web of Science ®Google Scholar
• Ashraf N, Sheikh T. Endoplasmic reticulum stress and oxidative stress in the pathogenesis of non-alcoholic fatty liver disease. Free Radic Res. 2015;49(12):1405–1418. doi:10.3109/10715762.2015.1078461
   PubMed Web of Science ®Google Scholar
• Asrih M, Jornayvaz FR. Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance. J Endocrinol. 2013;218(3):R25–R36. doi:10.1530/JOE-13-0201
   PubMed Web of Science ®Google Scholar
• Chen Z, Tian R, She Z, Cai J, Li H. Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease. Free Radic Biol Med. 2020;152:116–141. doi:10.1016/j.freeradbiomed.2020.02.025
   PubMed Web of Science ®Google Scholar
• Chen Z, Yu R, Xiong Y, Du F, Zhu S. A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease. Lipids Health Dis. 2017;16(1):203. doi:10.1186/s12944-017-0572-9
   PubMed Web of Science ®Google Scholar
• Rindler PM, Crewe CL, Fernandes J, Kinter M, Szweda LI. Redox regulation of insulin sensitivity due to enhanced fatty acid utilization in the mitochondria. Am J Physiol Heart Circ Physiol. 2013;305(5):H634–H643. doi:10.1152/ajpheart.00799.2012
   PubMed Web of Science ®Google Scholar
• Santoleri D, Titchenell PM. Resolving the paradox of hepatic insulin resistance. Cell Mol Gastroenterol Hepatol. 2019;7(2):447–456. doi:10.1016/j.jcmgh.2018.10.016
   PubMed Web of Science ®Google Scholar
• Denk H, Abuja PM, Zatloukal K. Animal models of NAFLD from the pathologist’s point of view. Biochimica et Biophysica Acta. 2019;1865(5):929–942. doi:10.1016/j.bbadis.2018.04.024
   Web of Science ®Google Scholar
• Xu Y, Guo W, Zhang C, et al. Herbal medicine in the treatment of non-alcoholic fatty liver diseases-efficacy, action mechanism, and clinical application. Front Pharmacol. 2020;11. doi:10.3389/fphar.2020.00601
   Web of Science ®Google Scholar
• Vinholes J, Rudnitskaya A, Gonçalves P, Martel F, Coimbra MA, Rocha SM. Hepatoprotection of sesquiterpenoids: a quantitative structure–activity relationship (QSAR) approach. Food Chem. 2014;146:78–84. doi:10.1016/j.foodchem.2013.09.039
   PubMed Web of Science ®Google Scholar
• Jahangeer M, Fatima R, Ashiq M. Therapeutic and biomedical potentialities of terpenoids–a review. J Pure Appl Microbiol. 2021;15(2):471–483. doi:10.22207/JPAM.15.2.04
   Web of Science ®Google Scholar
• Hosseinzadeh H, Shakib SS, Sameni AK, Taghiabadi E. Acute and subacute toxicity of safranal, a constituent of saffron, in mice and rats. Iran J Pharm Res. 2013;12(1):93.
   PubMed Web of Science ®Google Scholar
• Mashmoul M, Azlan A, Mohtarrudin N, et al. Protective effects of saffron extract and crocin supplementation on fatty liver tissue of high-fat diet-induced obese rats. BMC Complement Altern Med. 2016;16(1):1–7. doi:10.1186/s12906-016-1381-9
   PubMed Web of Science ®Google Scholar
• Malekzadeh S, Heidari MR, Razavi BM, Rameshrad M, Hosseinzadeh H. Effect of safranal, a constituent of saffron, on olanzapine (an atypical antipsychotic) induced metabolic disorders in rat. Iran J Basic Med Sci. 2019;22(12):1476. doi:10.22038/IJBMS.2019.13992
   PubMed Web of Science ®Google Scholar
• Karafakıoğlu YS, Bozkurt MF, Hazman Ö, Fıdan AF. Efficacy of safranal to cisplatin-induced nephrotoxicity. Biochem J. 2017;474(7):1195–1203. doi:10.1042/BCJ20160971
   PubMed Web of Science ®Google Scholar
• Lertnimitphun P, Jiang Y, Kim N, et al. Safranal alleviates dextran sulfate sodium-induced colitis and suppresses macrophage-mediated inflammation. Front Pharmacol. 2019;10:1281. doi:10.3389/fphar.2019.01281
   PubMed Web of Science ®Google Scholar
• Hamza AA, El Hodairy F, Badawi A. Safranal ameliorates Sodium Valproate-induced liver toxicity in rats by targeting gene expression, oxidative stress and apoptosis. J Biomed Pharm Res. 2015;4(6):46–60.
   Google Scholar
• Pan P, Qiao L, Wen X. Safranal prevents rotenone-induced oxidative stress and apoptosis in an in vitro model of Parkinson’s disease through regulating Keap1/Nrf2 signaling pathway. Cell Mol Biol. 2016;62(14):11–17. doi:10.14715/cmb/2016.62.14.2
   PubMed Web of Science ®Google Scholar
• Zhao D, Gao F, Zhu H, et al. Selenium-enriched Bifidobacterium longum DD98 relieves metabolic alterations and liver injuries associated with obesity in high-fat diet-fed mice. J Funct Foods. 2020;72:104051. doi:10.1016/j.jff.2020.104051
   Web of Science ®Google Scholar
• Ma Z, Chu L, Liu H, et al. Beneficial effects of paeoniflorin on non-alcoholic fatty liver disease induced by high-fat diet in rats. Sci Rep. 2017;7(1):1–10. doi:10.1038/s41598-016-0028-x
   PubMed Web of Science ®Google Scholar
• Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313–1321. doi:10.1002/hep.20701
   PubMed Web of Science ®Google Scholar
• Folch J, Lees M, Stanley GS. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226(1):497–509. doi:10.1016/S0021-9258(18)64849-5
   PubMed Web of Science ®Google Scholar
• Das S, Choudhuri D. Calcium supplementation shows a hepatoprotective effect against high-fat diet by regulating oxidative-induced inflammatory response and lipogenesis activity in male rats. J Tradit Complement Med. 2020;10(5):511–519. doi:10.1016/j.jtcme.2019.06.002
   PubMedGoogle Scholar
• Waterborg JH. The Lowry method for protein quantitation. In: The Protein Protocols Handbook. Springer; 2009:7–10.
   Google Scholar
• Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95(2):351–358. doi:10.1016/0003-2697(79)90738-3
   PubMed Web of Science ®Google Scholar
• Tiwari BK, Kumar D, Abidi A, Rizvi SI. Efficacy of composite extract from leaves and fruits of medicinal plants used in traditional diabetic therapy against oxidative stress in alloxan-induced diabetic rats. Int Sch Res Notices. 2014;2014:608590.
   Google Scholar
• Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem. 1982;126(1):131–138. doi:10.1016/0003-2697(82)90118-X
   PubMed Web of Science ®Google Scholar
• Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem. 1968;25:192–205. doi:10.1016/0003-2697(68)90092-4
   PubMed Web of Science ®Google Scholar
• Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70(1):158–169.
   PubMed Web of Science ®Google Scholar
• Habig WH. Glutathione S-transferase: the first enzymatic step in mercapturic acid formation. J Biol Chem. 1974;249:7130–7139. doi:10.1016/S0021-9258(19)42083-8
   PubMed Web of Science ®Google Scholar
• Li X. Improved pyrogallol autoxidation method: a reliable and cheap superoxide-scavenging assay suitable for all antioxidants. J Agric Food Chem. 2012;60(25):6418–6424. doi:10.1021/jf204970r
   PubMed Web of Science ®Google Scholar
• Aebi H. [13] Catalase in vitro. In: Methods in Enzymology. Vol. 105. Academic Press; 1984:121–126.
   Google Scholar
• Reddy G, Enwemeka C. A simplified method for the analysis of in biological tissues hydroxyproline. Clin Biochem. 1996;29:3.
   Web of Science ®Google Scholar
• Ichimura M, Kawase M, Masuzumi M, et al. High-fat and high-cholesterol diet rapidly induces non-alcoholic steatohepatitis with advanced fibrosis in S Prague–D awley rats. Hepatology Res. 2015;45(4):458–469. doi:10.1111/hepr.12358
   PubMed Web of Science ®Google Scholar
• Li S, Meng F, Liao X, et al. Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats. PLoS One. 2014;9(1):e86724. doi:10.1371/journal.pone.0086724
   PubMed Web of Science ®Google Scholar
• Ipsen DH, Lykkesfeldt J, Tveden-Nyborg P. Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell Mol Life Sci. 2018;75(18):3313–3327. doi:10.1007/s00018-018-2860-6
   PubMed Web of Science ®Google Scholar
• Zhang L-J, Yang B, Yu B-P. Paeoniflorin protects against nonalcoholic fatty liver disease induced by a high-fat diet in mice. Biol Pharm Bull. 2015:b14–00892. doi:10.1248/bpb.b14-00892
   Web of Science ®Google Scholar
• Zaitone SA, Barakat BM, Bilasy SE, Fawzy MS, Abdelaziz EZ, Farag NE. Protective effect of boswellic acids versus pioglitazone in a rat model of diet-induced non-alcoholic fatty liver disease: influence on insulin resistance and energy expenditure. Naunyn Schmiedebergs Arch Pharmacol. 2015;388(6):587–600. doi:10.1007/s00210-015-1102-9
   PubMed Web of Science ®Google Scholar
• Bharti S, Golechha M, Kumari S, Siddiqui KM, Arya DS. Akt/GSK-3β/eNOS phosphorylation arbitrates safranal-induced myocardial protection against ischemia–reperfusion injury in rats. Eur J Nutr. 2012;51(6):719–727. doi:10.1007/s00394-011-0251-y
   PubMed Web of Science ®Google Scholar
• Chen H-J, Liu J. Actein ameliorates hepatic steatosis and fibrosis in high fat diet-induced NAFLD by regulation of insulin and leptin resistant. Biomed Pharmacother. 2018;97:1386–1396. doi:10.1016/j.biopha.2017.09.093
   PubMed Web of Science ®Google Scholar
• Bharathi V, Rengarajan R, Radhakrishnan R, et al. Effects of a medicinal plant Macrotyloma uniflorum (Lam.) Verdc. formulation (MUF) on obesity-associated oxidative stress-induced liver injury. Saudi J Biol Sci. 2018;25(6):1115–1121. doi:10.1016/j.sjbs.2018.03.010
   PubMed Web of Science ®Google Scholar
• Ozenirler S, Erkan G, Konca Degertekin C, et al. The relationship between advanced oxidation protein products (AOPP) and biochemical and histopathological findings in patients with nonalcoholic steatohepatitis. J Dig Dis. 2014;15(3):131–136. doi:10.1111/1751-2980.12113
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zhang L, Ouyang X, et al. Advanced oxidation protein products play critical roles in liver diseases. Eur J Clin Invest. 2019;49(6):e13098. doi:10.1111/eci.13098
   PubMed Web of Science ®Google Scholar
• Zhong X, Liu H. Baicalin attenuates diet induced nonalcoholic steatohepatitis by inhibiting inflammation and oxidative stress via suppressing JNK signaling pathways. Biomed Pharmacother. 2018;98:111–117. doi:10.1016/j.biopha.2017.12.026
   PubMed Web of Science ®Google Scholar
• Overi D, Carpino G, Franchitto A, Onori P, Gaudio E. Hepatocyte injury and hepatic stem cell niche in the progression of non-alcoholic steatohepatitis. Cells. 2020;9(3):590. doi:10.3390/cells9030590
   PubMed Web of Science ®Google Scholar
• Younes R, Burgoyne R, Tiniakos D, Govaere O. Clinical implications of hepatic progenitor cell activation in non-alcoholic fatty liver disease. Hepatoma Res. 2021;7:15.
   Google Scholar